4.400USD-10.93%Mkt Cap: 18.27M USDP/E: —Last update: 2026-05-29
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap18.27M USD
Enterprise Value17.87M USD
Revenue (TTM)209.03K USD
Gross Profit48.95K USD
Net Income (TTM)-13.38M USD
Revenue/Share0.0560 USD
Last Price4.400 USD
Fiscal Year EndDec 2024
MR QuarterSep 2025
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS98978N2009
Valuation
P/E (Trailing)—
P/E (Forward)-3.67
PEG—
EV/EBITDA—
EV/Revenue85.50
P/S87.39
P/B-5.13
EPS (TTM)-2.18
EPS (Forward)-1.20
52W Range
1.11018% of range19.65
52W High19.65 USD
52W Low1.110 USD
Profitability
Gross Margin31.14%
Oper. Margin-1551.76%
EBITDA Margin0.00%
Profit Margin-8513.44%
ROE2599.52%
ROA-814.60%
Growth
Revenue Growth108.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.31M USD
CapEx (TTM)—
FCF Margin-1252.12%
FCF Yield-14.33%
Net Debt762.47K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.49
Current Ratio0.08
Quick Ratio0.02
Book Value/Sh-0.8580 USD
Cash/Share0.0150 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateOct 27, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.15M
Float1.94M
Insiders47.46%
Institutions0.11%
Short Interest
Short Ratio6.7d
Short % Float2.61%
Short % Out.2.04%
Shares Short35.47K
Short (prev mo.)12.81K
Technical
SMA 504.088 (+7.6%)
SMA 2009.760 (-54.9%)
Beta0.06
S&P 52W Chg27.70%
Avg Vol (30d)4.68K
Avg Vol (10d)360
Technical Indicators
RSI (14)62.9
MACD0.1279
MACD Signal-0.0693
MACD Hist.+0.1972
BB Upper4.725 USD
BB Middle3.833 USD
BB Lower2.942 USD
BB Width46.50%
ATR (14)0.4330 USD
Vol Ratio (20d)0.00x